78/100 B+ · Low risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

Cibus, Inc.

Active operating 📍 San Diego

operating

B+

Overview

Cibus, Inc. is a operating registered in SAN DIEGO, United States. With reported revenue of 3.6M USD in 2025. Its TraceComp score of 53 (C) indicates elevated risk requiring further due diligence.

Company Information

Registration Number
0001705843
Legal Form
operating
Activity
Agricultural Chemicals
Address
San Diego

Financial Profile

Latest filed accounts: FY 2025

Revenue (2025) 3,639,000 USD
Net Income -127,085,000 USD
Total Assets 305,047,000 USD
Altman Z

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Research Output

Active research organization. 55 publications · 8,491 citations · h-index 48 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Biochemistry, Genetics and Molecular Biology (59%) · Agricultural and Biological Sciences (36%) · Pharmacology, Toxicology and Pharmaceutics (5%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2025

Similar Companies

Data Sources & Freshness

Data sourced from: official public registries. Profile completeness: 70%.